This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A new study suggests a potassium channel blocker nasal spray could reduce the severity of sleep apnea.
The company came to an agreement with the FDA to cease sales until the machines’ health hazards can be fully addressed.
Philips faces new FDA scrutiny over life-threatening defects of its DreamStation 2 CPAP.
